Are you a new member? Sign up now
Login area
| Sign up
close
XOLAIR - 150mg - 1 x 2ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R03DX05 | BioTech | Omalizumab - 150mg | 5194/945 | 23729/06 | XOLAIR | 150mg | 1 x 2ml | Injectable lyophilised powder for solution+diluent | SC | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 50,309,160 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 05/02/20 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R03DX05 | BioTech | Omalizumab - 150mg | 5194 | 23729/06 | XOLAIR | 150mg | 1 x 2ml | Injectable lyophilised powder for solution+diluent | SC | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 825,193 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 05/02/20 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024